[HTML][HTML] The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early …

K Huang, T Qian, W Chen, M Lao, H Li, WC Lin… - BMC cancer, 2024 - Springer
Background The role of adjuvant transcatheter arterial chemoembolization (TACE) following
repeated resection/ablation for recurrent hepatocellular carcinoma (HCC) remains …

Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a …

Z Peng, M Wei, S Chen, M Lin, C Jiang, J Mei, B Li… - European …, 2018 - Springer
Objectives To compare retrospectively the efficacy of transcatheter arterial
chemoembolization (TACE) plus radiofrequency ablation (RFA)(TACE-RFA) with that of …

Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching …

C Wang, Y Liao, J Qiu, Y Yuan, Y Zhang, K Li… - Journal of cancer …, 2020 - Springer
Purpose The recurrence after curative hepatectomy is common. Limited data have
investigated the effect of transcatheter arterial chemoembolization (TACE) combined with …

Optimal treatment strategy for recurrent hepatocellular carcinoma based on recurrence time and tumor size: a propensity score matching study

W Wan, H Zhang, T Ji, L Zhang, KG Luo… - Clinics and Research in …, 2023 - Elsevier
Background Recurrent hepatocellular carcinoma (RHCC) is commonly treated with
transcatheter arterial chemoembolization (TACE) combined with microwave ablation (MWA) …

Long-term outcomes of transarterial chemoembolization combined with radiofrequency ablation versus transarterial chemoembolization alone for recurrent …

Q Song, W Ren, L Fan, M Zhao, L Mao, S Jiang… - Digestive diseases and …, 2020 - Springer
Background There is lack of data for identifying optimal local therapy for the management of
recurrent hepatocellular carcinoma (HCC) after hepatic resection. Aims A retrospective study …

[HTML][HTML] Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods

MJ Kuo, LR Mo, CL Chen - BMC cancer, 2021 - Springer
Background We quantified the elusive effects of putative factors on the clinical course of
early hepatocellular carcinoma (HCC) after primary surgical or nonsurgical curative …

[HTML][HTML] Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma After …

X Zheng, Y Ren, H Hu, K Qian - Frontiers in Oncology, 2021 - frontiersin.org
Background The purpose of this study was to compare the efficacy and safety of transarterial
chemoembolization (TACE) in combination with radiofrequency ablation (RFA)(TACE-RFA) …

Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled study

Z Wang, Z Ren, Y Chen, J Hu, G Yang, L Yu… - Clinical Cancer …, 2018 - AACR
Purpose: The survival of patients with hepatocellular carcinoma (HCC) recurrence after
curative resection is usually poor. We sought to evaluate the safety and efficacy of adjuvant …

[HTML][HTML] Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis

JH Jiang, Z Guo, HF Lu, XB Wang… - World journal of …, 2015 - ncbi.nlm.nih.gov
AIM: To compare survival and recurrence in hepatocellular carcinoma (HCC) patients who
did or did not receive adjuvant transarterial chemoembolization (TACE). METHODS: A …

Salvage hepatectomy for recurrent hepatocellular carcinoma after radiofrequency ablation and/or transcatheter arterial chemoembolization: a propensity score …

T Orimo, T Kamiyama, H Yokoo, K Wakayama… - Digestive …, 2018 - karger.com
Aim: We aimed to evaluate the short-and long-term surgical outcomes of salvage
hepatectomy for recurrent hepatocellular carcinoma (HCC) after radiofrequency ablation …